News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,277 Results
Type
Article (14053)
Company Profile (304)
Press Release (248920)
Section
Business (79551)
Career Advice (152)
Deals (13210)
Drug Delivery (34)
Drug Development (50578)
Employer Resources (31)
FDA (5739)
Job Trends (5247)
News (144706)
Policy (10109)
Tag
Academia (909)
Alliances (21609)
Alzheimer's disease (762)
Approvals (5727)
Artificial intelligence (70)
Bankruptcy (99)
Best Places to Work (4668)
Biotechnology (249)
Breast cancer (112)
Cancer (920)
Cardiovascular disease (71)
Career advice (132)
CAR-T (76)
Cell therapy (220)
Clinical research (40393)
Collaboration (316)
Compensation (134)
COVID-19 (1010)
C-suite (79)
Cystic fibrosis (67)
Data (996)
Diabetes (87)
Diagnostics (1215)
Drug discovery (57)
Earnings (29066)
Events (47359)
Executive appointments (253)
FDA (6124)
Funding (312)
Gene editing (64)
Gene therapy (166)
GLP-1 (311)
Government (1075)
Healthcare (6595)
Infectious disease (1048)
Inflammatory bowel disease (98)
IPO (7205)
Job creations (860)
Job search strategy (127)
Layoffs (190)
Legal (1379)
Lung cancer (137)
Lymphoma (67)
Manufacturing (87)
Medical device (2581)
Medtech (2582)
Mergers & acquisitions (6151)
Metabolic disorders (262)
Neuroscience (1009)
NextGen Class of 2024 (2020)
Non-profit (851)
Northern California (1111)
Obesity (142)
Opinion (91)
Parkinson's disease (78)
Patents (63)
People (25150)
Phase I (14203)
Phase II (18733)
Phase III (11965)
Pipeline (370)
Postmarket research (855)
Preclinical (5977)
Radiopharmaceuticals (206)
Rare diseases (205)
Real estate (1414)
Regulatory (8381)
Research institute (939)
Southern California (990)
Startups (1966)
United States (8818)
Vaccines (165)
Weight loss (84)
Date
Last 7 days (93)
Last 30 days (993)
Last 365 days (20194)
2025 (53)
2024 (20665)
2023 (22507)
2022 (26896)
2021 (27874)
2020 (23451)
2019 (16381)
2018 (11844)
2017 (13815)
2016 (11923)
2015 (14436)
2014 (10482)
2013 (7524)
2012 (7585)
2011 (7663)
2010 (7460)
Location
Africa (146)
Asia (17002)
Australia (2863)
California (2515)
Canada (823)
China (218)
Colorado (93)
Connecticut (106)
Europe (36540)
Florida (277)
Georgia (71)
Illinois (158)
Indiana (62)
Maryland (339)
Massachusetts (1975)
Michigan (58)
Minnesota (102)
New Jersey (659)
New York (698)
North Carolina (422)
Northern California (1111)
Ohio (84)
Pennsylvania (483)
South America (207)
Southern California (990)
Texas (285)
Washington State (252)
263,277 Results for "hls therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HLS Therapeutics Announces Q3 2024 Financial Results
November 8, 2024
·
18 min read
Press Releases
HLS Therapeutics to Host Q3 Fiscal 2024 Financial Results Conference Call
October 24, 2024
·
1 min read
Press Releases
HLS Therapeutics Announces Q2 2024 Financial Results
August 8, 2024
·
18 min read
Press Releases
HLS Therapeutics to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
August 28, 2024
·
1 min read
Press Releases
HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call
July 25, 2024
·
1 min read
Press Releases
HLS Announces Reimbursement for Vascepa® under Alberta’s Provincial Drug Plan
July 29, 2024
·
4 min read
Business
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Initiate First-in-Human Phase 1 Clinical Study of HL192
HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinson’s Disease in collaboration with NurrOn Pharmaceuticals.
October 12, 2023
·
9 min read
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory was inaugurated in Harbin, Heilongjiang province, China, marking a significant advance in the province’s efforts to address public health challenges.
May 13, 2024
·
2 min read
Business
Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada
Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with HLS Therapeutics Inc. (“HLS”) (TSX:HLS) to distribute five MyCare™ Psychiatry Laboratory Assays used to measure the six most commonly prescribed antipsychotic drugs in Canada.
November 18, 2021
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 26,328
Next
